Clinical characterization of breakthrough bacteraemia: a survey of 392 episodes

被引:28
作者
Dupla, ML
Martinez, JA
Vidal, F
Almela, M
Lopez, J
Marco, F
Soriano, A
Richart, C
Mensa, J
机构
[1] Univ Rovira & Virgili, Hosp Univ Joan XXIII, Med Interna Serv, Tarragona 43007, Spain
[2] Hosp Clin Barcelona, Microbiol Serv, Barcelona, Spain
[3] Hosp Clin Barcelona, Servei Malalties Infeccioses, Barcelona, Spain
关键词
breakthrough bacteraemia; coagulase-negative staphylococci; intravenous catheter; nosocomial bacteraemia; P; aeruginosa; S; aureus;
D O I
10.1111/j.1365-2796.2005.01513.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Few data are available on the clinical features of patients who develop breakthrough bacteraemia, understood as positive blood cultures despite appropriate antibiotic therapy. Objectives. To determine the clinical significance and outcome of a large series of breakthrough bacteraemia. Design. Retrospective analysis of a prospectively collected database. Setting. Two university-affiliated hospitals in Catalonia, Spain. Subjects. A total of 392 individuals who suffered an episode of breakthrough bacteraemia recorded between 1997 and 2002. Interventions. Demographic characteristics, underlying diseases, origin of infection, sources of infection, microorganisms isolated, McCabe and Jackson prognostic criteria, and mortality were analysed. Results. Breakthrough bacteraemia was detected in 392 of 6324 (6.1%) episodes of bacteraemia. Eighty per cent of episodes were nosocomial. The most frequent source of infection in breakthrough bacteraemia was endovascular (70%). Coagulase-negative staphylococci, Staphylococcus aureus, and Pseudomonas aeruginosa were the most significant microorganisms involved. Nosocomial acquisition together with selected sources (central venous catheter, endocarditis and other endovascular foci), underlying conditions (neutropenia, polytraumatism, allogenic bone marrow and kidney transplantation), and particular microbial aetiologies (S. aureus, P. aeruginosa and polymicrobial) were independently associated with increased risk for developing breakthrough bacteraemia. Crude mortality rate was greater in patients with breakthrough bacteraemia (16% vs. 12.3%; P < 0.05), and this condition was an independent predictor of death (OR 1.4, 95% CI, 1-1.9; P = 0.04). Conclusions. In view of a case of breakthrough bacteraemia it is mandatory to search for an endovascular focus. Empiric treatment should be directed to cover S. aureus, coagulase-negative staphylococci and nonfermentative Gram-negative bacilli. Breakthrough bacteraemia is an independent predictor of death.
引用
收藏
页码:172 / 180
页数:9
相关论文
共 39 条
[1]   SIMULTANEOUS ANTIBIOTIC LEVELS IN BREAKTHROUGH GRAM-NEGATIVE ROD BACTEREMIA [J].
ANDERSON, ET ;
YOUNG, LS ;
HEWITT, WL .
AMERICAN JOURNAL OF MEDICINE, 1976, 61 (04) :493-497
[2]   Recurrent vancomycin-resistant Enterococcus bacteremia:: Prevalence, predisposing factors, and strain relatedness [J].
Baran, J ;
Riederer, KM ;
Ramanathan, J ;
Khatib, R .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (09) :1381-1383
[3]   New tools in diagnosing catheter-related infections [J].
Blot, F ;
Nitenberg, G ;
Brun-Buisson, C .
SUPPORTIVE CARE IN CANCER, 2000, 8 (04) :287-292
[4]   Catheter-related infections:: diagnosis and intravascular treatment [J].
Bouza, E ;
Burillo, A ;
Muñoz, P .
CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 (05) :265-274
[5]   Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: Effect of augmented gram-positive activity on infectious morbidity [J].
Bow, EJ ;
Mandell, LA ;
Louie, TJ ;
Feld, R ;
Palmer, M ;
Zee, B ;
Pater, J .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (03) :183-+
[6]   Persistent bacteremia and outcome in late onset infection among infants in a neonatal intensive care unit [J].
Chapman, RL ;
Faix, RG .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (01) :17-21
[7]   Persistent bacteremia in the absence of defined intravascular foci: Clinical significance and risk factors [J].
Chowers, MY ;
Gottesman, B ;
Paul, M ;
Weinberger, M ;
Pitlik, S ;
Leibovici, L .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (10) :592-596
[8]   Bacterial translocation of enteric organisms in patients with cirrhosis [J].
Cirera, I ;
Bauer, TM ;
Navasa, M ;
Vila, J ;
Grande, L ;
Taurá, P ;
Fuster, J ;
García-Valdecasas, JC ;
Lacy, A ;
Suárez, MJ ;
Rimola, A ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 2001, 34 (01) :32-37
[9]   RIGHT-SIDED ENDOCARDITIS CAUSED BY STAPHYLOCOCCUS-AUREUS IN DRUG-ABUSERS [J].
FORTUN, J ;
PEREZMOLINA, JA ;
ANON, MT ;
MARTINEZBELTRAN, J ;
LOZA, E ;
GUERRERO, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) :525-528
[10]   Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin [J].
Kelley, MA ;
Weber, DJ ;
Gilligan, P ;
Cohen, MS .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (04) :1008-1011